Concentrating on Australia: Live Resin Maker Enters $1.5B Market Down Under

The Australian market, while still in its infancy operating largely as a medical cannabis market, could grow to as large as $1.55 billion by 2024 according to Prohibition Partners, and Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF), the first company to ship live resin to Australia, is looking to capture market share with its innovative industry leading products.

Toronto-based Heritage announced this week that it has received a purchase order from an Australian company for the supply of 15,000 units of Live Resin concentrate vape cartridges. Heritage recently received import permits allowing the Company to ship products to this growing market. With revenue being driven in both Canada, the U.S., Heritage is eyeing becoming a global leader in cannabis by expanding into a wider international market.

“We are experiencing an increased amount of requests for our concentrates from other international buyers,” said David Schwede, CEO of Heritage. “With our superior products we are confident that our trademark resins will be well received down under.”

Heritage is a leading cannabis company serving both the medical and recreational legal cannabis markets in Canada and the U.S. The company’s portfolio includes the brands Purefarma, Pura Vida, RAD, Premium 5, Thrifty, feelgood and the CB4 suite of medical products in Canada and ArthroCBD in the U.S.

For more information about Heritage, visit here.